Cargando…
Protocol for a MULTI-centre feasibility study to assess the use of (99m)Tc-sestaMIBI SPECT/CT in the diagnosis of kidney tumours (MULTI-MIBI study)
INTRODUCTION: The incidence of renal tumours is increasing and anatomic imaging cannot reliably distinguish benign tumours from renal cell carcinoma. Up to 30% of renal tumours are benign, with oncocytomas the most common type. Biopsy has not been routinely adopted in many centres due to concerns su...
Autores principales: | Warren, Hannah, Wagner, Thomas, Gorin, Michael A, Rowe, Steven, Holman, Beverley Fiona, Pencharz, Deborah, El-Sheikh, Soha, Barod, Ravi, Patki, Prasad, Mumtaz, Faiz, Bex, Axel, Kasivisvanathan, Veeru, Moore, Caroline M, Campain, Nicholas, Cartledge, Jon, Scarsbrook, Andrew, Hassan, Fahim, O'Brien, Tim S, Stewart, Grant D, Mendichovszky, Iosif, Dizdarevic, Sabina, Alanbuki, Ammar, Wildgoose, William H, Wah, Tze, Vindrola-Padros, Cecilia, Pizzo, Elena, Dehbi, Hakim-Moulay, Lorgelly, Paula, Gurusamy, Kurinchi, Emberton, Mark, Tran, Maxine G B |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9884914/ https://www.ncbi.nlm.nih.gov/pubmed/36693694 http://dx.doi.org/10.1136/bmjopen-2022-067496 |
Ejemplares similares
-
Reverse perfusion pattern in myocardial spect with 99mTc-SestaMIBI
por: Schillaci, O, et al.
Publicado: (2013) -
Ectopic Parathyroid Incidentaloma on Tc99m SestaMIBI Myocardial Perfusion Imaging
por: Hussain, Rola Aatif Hasan, et al.
Publicado: (2017) -
Osteosclerotic and osteolytic manifestations of hyperparathyroidism in a case of Tc99m SestaMIBI positive parathyroid adenoma
por: Das, Kalpa Jyoti, et al.
Publicado: (2015) -
The role of (18)F-FCH PET/CT in patients with uremic hyperparathyroidism compared with (99m)Tc-sestaMIBI SPECT/CT and ultrasonography
por: Xue, Yu, et al.
Publicado: (2019) -
The Use of (99m)Tc-Methoxy-isobutyl-isonitrile (sestaMIBI) Uptake on Scintigraphy ((99m)-STS) in Amiodarone-Induced Thyrotoxicosis: Case Series and Review of the Literature
por: Elshimy, Ghada, et al.
Publicado: (2020)